BioSpace News Archive

FDA

Will 2018 Be Another Record Year for FDA Approvals?

2017 was the second-best year for FDA approvals since 1996.

January 8, 2018
·
1 min read
Deals

Rejected Again: Ablynx Turns Down Novo Nordisk’s Sweetened $3.1B Bid

The offers underline Novo Nordisk’s interest in expanding beyond diabetes and into the rare diseases market.

January 8, 2018
·
2 min read
·
Mark Terry
Policy

pSivida Submits NDA for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA

The FDA will next determine whether pSivida’s NDA is complete and acceptable for review.

January 8, 2018
·
6 min read
Genetron Health Raises $61M for Genomics-Oncology Services

Beijing’s Genetron Health, a precision medicine oncology company, raised over $61M in a Series C round led by Zhongjin Kangrui Medical Industrial Fund.

January 8, 2018
·
1 min read
BioCapital

Can 2018 Possibly Rival 2017’s Biotechs Record Venture Capital Splurge?

A look at whether big money and big deals will be in store for 2018.

January 8, 2018
·
2 min read
·
Karl Thiel
Drug Development

Biotech Unicorn Moderna Details Game Plan, Reveals Infectious Disease Programs

Moderna unleashed a torrent of updates yesterday.

January 8, 2018
·
2 min read
·
Mark Terry
Business

ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer technology

The targets that will be pursued in the collaboration and financial details about the collaboration are not disclosed.

January 8, 2018
·
4 min read
Business

Emerald Health Therapeutics Appoints Paul R. Dillman, Jr. to Vice President of Sales and Marketing

Senior marketing executive with three decades global consumer packaged goods experience to lead Emerald’s marketing and sales strategy.

January 8, 2018
·
5 min read
Deals

Guerbet Pays $23.7M for Israeli Medtech Accurate Medical Therapeutics

Accurate has developed a range of microcatheters for embolization procedures of tumors and vascular aneurysms.

January 8, 2018
·
5 min read
Business

Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result

The company expects reported revenue for the fourth quarter 2017 to be approximately $365 million, an increase of over 40% compared to $255.7 million for the fourth quarter of 2016.

January 8, 2018
·
7 min read